COVID-19 Presentation in Association with Myasthenia Gravis: A Case Report and Review of the Literature

被引：20

作者：

Aksoy, Elif ^{[1
]}

Oztutgan, Turgut ^{[1
]}

机构：

[1] Kolan Int Hosp, Dept Pulmonol, Darulaceze Cd 14, TR-34384 Istanbul, Turkey

来源：

CASE REPORTS IN INFECTIOUS DISEASES | 2020年 / 2020卷

关键词：

THYMECTOMY;

D O I：

10.1155/2020/8845844

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Currently, there are scarce data on how COVID-19 affects people with myasthenia gravis. Theoretically, there is a higher risk of experiencing severe manifestations of COVID-19 due to the common use of immunosuppressive drugs and potential respiratory failure in relation to respiratory muscle weakness. This is one of the early cases of COVID-19 reported in association with myasthenia gravis. Here, we highlight the prognosis, discuss the pathophysiological mechanisms, and prompt the consideration of convalescent plasma therapy in myasthenia gravis patients with concomitant COVID-19.

引用

页数：4

共 20 条

[1] Use of Convalescent Plasma Therapy in Two COVID-19 Patients With Acute Respiratory Distress Syndrome in Korea [J].

Ahn, Jin Young ;

Sohn, Yujin ;

Lee, Su Hwan ;

Cho, Yunsuk ;

Hyun, Jong Hoon ;

Baek, Yae Jee ;

Jeong, Su Jin ;

Kim, Jung Ho ;

Ku, Nam Su ;

Yeom, Joon-Sup ;

Roh, Juhye ;

Ahn, Mi Young ;

Chin, Bum Sik ;

Kim, Young Sam ;

Lee, Hyukmin ;

Yong, Dongeun ;

Kim, Hyun Ok ;

Kim, Sinyoung ;

Choi, Jun Yong .

JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (14)

[2] Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients? [J].

Amiral, Jean ;

Vissac, Anne Marie ;

Seghatchian, Jerard .

TRANSFUSION AND APHERESIS SCIENCE, 2020, 59 (03)

[3] COVID-19 in patients with myasthenia gravis [J].

Anand, Pria ;

Slama, Michael C. C. ;

Kaku, Michelle ;

Ong, Charlene ;

Cervantes-Arslanian, Anna M. ;

Zhou, Lan ;

David, William S. ;

Guidon, Amanda C. .

MUSCLE & NERVE, 2020, 62 (02) :254-258

[4] Immunotherapy in myasthenia gravis in the era of biologics [J].

Dalakas, Marinos C. .

NATURE REVIEWS NEUROLOGY, 2019, 15 (02) :113-124

[5] Myasthenic crisis in COVID-19 [J].

Delly, Fadi ;

Syed, Maryam J. ;

Lisak, Robert P. ;

Zutshi, Deepti .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 414

[6]

Diurno F, 2020, EUR REV MED PHARMACO, V24, P4040, DOI 10.26355/eurrev_202004_20875

[7] Inhibition of IL-6 overproduction by steroid treatment before transsternal thymectomy for myasthenia gravis: does it help stabilize perioperative condition? [J].

Endo, S ;

Hasegawa, T ;

Sato, Y ;

Otani, S ;

Saito, N ;

Tetsuka, K ;

Tezuka, Y ;

Sohara, Y .

EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (10) :768-773

[8] COVID-19 and neuromuscular disorders [J].

Guidon, Amanda C. ;

Amato, Anthony A. .

NEUROLOGY, 2020, 94 (22) :959-969

[9] Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic [J].

Jacob, Saiju ;

Muppidi, Srikanth ;

Guidon, Amanda ;

Guptill, Jeffrey ;

Hehir, Michael ;

Howard, James F., Jr. ;

Illag, Isabel ;

Mantegazza, Renato ;

Murai, Hiroyuki ;

Utsugisawa, Kimiaki ;

Vissing, John ;

Wiendl, Heinz ;

Nowak, Richard J. .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 412

[10] A glimpse into the eye of the COVID-19 cytokine storm [J].

Kuppalli, Krutika ;

Rasmussen, Angela L. .

EBIOMEDICINE, 2020, 55

← 1 2 →